<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories Ltd has informed the Bombay Stock Exchange that it does not qualify as a 'Large Corporate' under the SEBI framework for fund raising through debt securities (SEBI Circular dated November 26, 2018, as amended). Because of this, the company is not required to file the Annual Disclosure in Annexure B2 for the financial year ended March 31, 2025. The letter was signed by Prakhar Dubey, Company Secretary & Compliance Officer, on April 25, 2025. This is a routine compliance communication clarifying the company's exemption from a specific SEBI disclosure rule. No new financial or business information is being shared in this filing.
This is a non-event for shareholders. The filing simply confirms that Choksi Laboratories is too small to fall under the 'Large Corporate' category, so no additional debt-related disclosure is needed. There is no impact on the stock price, business operations, or shareholder value.